Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9–25 years: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9–25 years: A systematic review and meta-analysis

Published:2020-01 Issue:2 Volume:38 Page:119-134
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Li Yaowei,Zhu Pengfei,Wu Meifen,Zhang Yiqing,Li Li

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Cervical cancer: a global health crisis;Small;Cancer,2017

2. The causal relation between human papillomavirus and cervical cancer;Bosch;J Clin Pathol,2002

3. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers;zur;Cancer Res,1989

4. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease;Serrano;Infect Agents Cancer,2012

5. Sexual behaviour in context: a global perspective;Wellings;Lancet,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on HPV Vaccination;Diagnostics;2023-01-09

2. Vaccines;Side Effects of Drugs Annual;2022

3. Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine;Pediatric Infectious Disease Journal;2021-06-10

4. Vaccines;Side Effects of Drugs Annual;2021

5. Vaccination reaction rate is unaltered by ambient temperature on the day;Heliyon;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP